757 studies found for:    "Esophageal cancer"
Show Display Options
Rank Status Study
1 Completed Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer
Conditions: Esophageal Cancer;   Cancer of the Esophagus;   Esophagus Cancer;   Esophageal Neoplasm;   Cancer of Esophagus
Interventions: Drug: Irinotecan (drug);   Drug: Taxotere (drug);   Procedure: Radiotherapy (procedure);   Procedure: Esophagectomy (procedure)
2 Completed Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer
Conditions: Adenocarcinoma of the Esophagus;   Adenocarcinoma of the Gastroesophageal Junction;   Recurrent Esophageal Cancer;   Squamous Cell Carcinoma of the Esophagus;   Stage III Esophageal Cancer;   Stage IV Esophageal Cancer
Interventions: Drug: erlotinib hydrochloride;   Other: laboratory biomarker analysis
3 Recruiting Esophageal Cancer Genetics Studies
Condition: Esophageal Cancer
Intervention:
4 Active, not recruiting Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Conditions: Adenocarcinoma of the Esophagus;   Adenocarcinoma of the Gastroesophageal Junction;   Adenocarcinoma of the Stomach;   Squamous Cell Carcinoma of the Esophagus;   Stage II Esophageal Cancer;   Stage II Gastric Cancer;   Stage III Esophageal Cancer;   Stage III Gastric Cancer
Interventions: Drug: erlotinib hydrochloride;   Drug: oxaliplatin;   Drug: fluorouracil;   Radiation: radiation therapy;   Procedure: conventional surgery;   Other: immunohistochemistry staining method;   Procedure: positron emission tomography;   Procedure: computed tomography;   Procedure: laboratory biomarker analysis;   Genetic: gene expression analysis;   Radiation: fludeoxyglucose F 18
5 Unknown  Genetic and Environmental Risk Factors Related to Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Genetic: DNA analysis;   Genetic: polymorphism analysis;   Other: questionnaire administration
6 Terminated Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer
Conditions: Esophageal Neoplasms;   Carcinoma, Squamous Cell;   Adenocarcinoma;   Esophageal Cancer
Interventions: Drug: Capecitabine (Xeloda);   Drug: [18-F] Fluorodeoxyglucose (FDG);   Drug: 5-Fluorouracil (5-FU);   Drug: Carboplatin
7 Recruiting Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;
Conditions: Esophageal Neoplasm;   Esophageal Cancer TNM Staging Primary Tumor (T) T2;   Esophageal Cancer TNM Staging Primary Tumor (T) T3;   Esophageal Cancer TNM Staging Regional Lymph Nodes (N) N0;   Esophageal Cancer TNM Staging Distal Metastasis (M) M0
Intervention: Radiation: Prophylactic postoperative radiation therapy
8 Unknown  Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Drug: carboplatin;   Drug: fluorouracil;   Drug: paclitaxel;   Procedure: conventional surgery;   Radiation: radiation therapy
9 Active, not recruiting Esophageal Cancer in Northeastern Iran
Condition: Esophageal Cancer
Intervention:
10 Completed Cryotherapy for Barrett's Esophagus and Early Esophageal Cancers
Conditions: Barretts Esophagus;   Esophageal Cancer
Intervention: Procedure: Cryospray Ablation
11 Recruiting PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Esophageal Cancer
Interventions: Drug: FOLFOX regimen;   Drug: carboplatin;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin;   Drug: paclitaxel
12 Recruiting Spray Cryotherapy for Esophageal Cancer (ICE-CANCER)
Condition: Esophageal Cancer
Intervention: Device: Liquid nitrogen spray cryotherapy with the truFreeze device
13 Completed Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After Chemotherapy
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Esophageal Cancer
Intervention: Procedure: quality-of-life assessment
14 Unknown  Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Esophageal Cancer;   Gastric Cancer
Interventions: Genetic: DNA analysis;   Genetic: RNA analysis;   Genetic: microarray analysis;   Genetic: protein analysis;   Other: cytology specimen collection procedure;   Other: laboratory biomarker analysis;   Other: questionnaire administration
15 Unknown  Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Drug: Paclitaxel;   Drug: Capecitabine
16 Completed Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer
Conditions: Esophageal Cancer;   Gastric Cancer
Interventions: Drug: bryostatin 1;   Drug: paclitaxel
17 Recruiting Esophageal Cancer Tissue Banking
Condition: Esophageal Cancer
Intervention:
18 Unknown  S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by Surgery
Condition: Esophageal Cancer
Interventions: Drug: cisplatin;   Drug: tegafur-gimeracil-oteracil potassium;   Other: cytology specimen collection procedure;   Procedure: endoscopic biopsy
19 Completed Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: paclitaxel;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
20 Terminated Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By Surgery
Condition: Esophageal Cancer
Interventions: Drug: gefitinib;   Procedure: conventional surgery;   Procedure: enzyme inhibitor therapy;   Procedure: neoadjuvant therapy;   Procedure: protein tyrosine kinase inhibitor therapy;   Procedure: surgery

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years